We are live on ! Find out more
ABEO icon

Abeona Therapeutics
ABEO

71 hedge funds and large institutions have $141M invested in Abeona Therapeutics in 2025 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 27 increasing their positions, 12 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,505% more call options, than puts

Call options by funds: $2.86M | Put options by funds: $178K

125% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 12

75% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 8

9% more funds holding

Funds holding: 65 → 71 (+6)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

9.3% less ownership

Funds ownership: 70.44% → 61.14% (-9.3%)

17% less capital invested

Capital invested by funds: $170M → $141M (-$29.2M)

Holders
71
Holders Change
+6
Holders Change %
+9.23%
% of All Funds
0.95%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
14
Increased
27
Reduced
12
Closed
8
Calls
$2.86M
Puts
$178K
Net Calls
+$2.68M
Net Calls Change
-$885K

Top Buyers

Rank Fund Capital Flow
1
KCM
Kennedy Capital Management
Missouri
+$3.38M
2
Marshall Wace
Marshall Wace
United Kingdom
+$1.53M
3
JP Morgan Chase
JP Morgan Chase
New York
+$1.27M
4
WSL
Western Standard LLC
California
+$1.07M
5
Morgan Stanley
Morgan Stanley
New York
+$1M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$7.11M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$6.58M
3
Walleye Capital
Walleye Capital
New York
-$2.19M
4
Bank of America
Bank of America
North Carolina
-$734K
5
6CM
683 Capital Management
New York
-$635K
Name Holding Trade Value Shares
Change 		Change in
Stake
State Street
26
State Street
Massachusetts
$931K +$65.3K +12,000 +7%
Walleye Capital
27
Walleye Capital
New York
$873K -$2.19M -402,944 -69%
Northern Trust
28
Northern Trust
Illinois
$861K -$22.3K -4,109 -2%
Wellington Management Group
29
Wellington Management Group
Massachusetts
$729K +$325K +59,832 +64%
Renaissance Technologies
30
Renaissance Technologies
New York
$626K +$230K +42,300 +47%
Bank of America
31
Bank of America
North Carolina
$616K -$734K -135,024 -51%
Jane Street
32
Jane Street
New York
$614K -$13.9K -2,559 -2%
Bank of New York Mellon
33
Bank of New York Mellon
New York
$578K – – –
TI
34
Trexquant Investment
Connecticut
$568K +$276K +50,758 +74%
PAI
35
Palo Alto Investors
California
$518K – – –
Qube Research & Technologies (QRT)
36
Qube Research & Technologies (QRT)
United Kingdom
$477K -$336K -61,739 -38%
UBS Group
37
UBS Group
Switzerland
$473K +$198K +36,322 +58%
HF
38
HRT Financial
New York
$460K +$526K +96,655 New
Barclays
39
Barclays
United Kingdom
$403K +$156K +28,649 +51%
CCM
40
Connective Capital Management
California
$357K – – –
Balyasny Asset Management
41
Balyasny Asset Management
Illinois
$352K +$216K +39,721 +116%
OAC
42
OMERS Administration Corp
Ontario, Canada
$344K +$38.9K +7,155 +11%
SSA
43
Schonfeld Strategic Advisors
New York
$309K +$20.4K +3,745 +6%
GCP
44
GSA Capital Partners
United Kingdom
$304K -$232K -42,690 -40%
LPL Financial
45
LPL Financial
California
$278K +$41.1K +7,550 +15%
JG
46
Jain Global
New York
$219K +$250K +45,940 New
Squarepoint
47
Squarepoint
New York
$181K +$141K +25,913 +215%
Citadel Advisors
48
Citadel Advisors
Florida
$153K +$167K +30,762 +2,400%
LP
49
LMR Partners
United Kingdom
$129K +$147K +27,120 New
QC
50
Quantessence Capital
New York
$124K +$142K +26,087 New
1
2
3 4

ABEO Hedge Fund Activity: Q1 2025 in Review

71 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Abeona Therapeutics (ABEO) for Q1 2025, worth a combined $141M — down 17% from $170M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new ABEO positions and 8 closed out — a net gain of 6 holders — while 27 added to existing stakes and 12 trimmed.

The largest buyer was Kennedy Capital Management, opening a new position worth an estimated $3.38M. The largest seller was Millennium Management, cutting an estimated $7.11M.

  • 71 institutional investors held Abeona Therapeutics (ABEO) as of Q1 2025, up from 65 in Q4 2024.
  • Funds reported $141M of Abeona Therapeutics stock for Q1 2025, down 17% quarter-over-quarter.
  • 14 funds opened new Abeona Therapeutics positions in Q1 2025 and 8 closed out, a net change of +6 holders.
  • The largest Abeona Therapeutics buyer in Q1 2025 was Kennedy Capital Management, an estimated $3.38M added.
  • The largest Abeona Therapeutics seller in Q1 2025 was Millennium Management, an estimated $7.11M sold.

Based on aggregated 13F filings for Q1 2025.